Tag: Movement disorder

While often used for other medication-induced movement issues, evidence shows that anticholinergic drugs like benztropine are contraindicated for tardive dyskinesia (TD) and can, in fact, make the condition worse. Understanding this crucial distinction is vital for patients and clinicians alike, especially since improper use remains a documented issue.

Approximately 20-50% of patients on long-term antipsychotic treatment, particularly older-generation drugs, have developed tardive dyskinesia (TD), a potentially irreversible side effect. This condition manifests as involuntary, repetitive movements and is a significant concern for those undergoing treatment with these vital medications.

While there is currently no single cure or FDA-approved treatment for the most common forms of cerebellar ataxia, particularly hereditary types, there are medications and therapies available to manage symptoms. The primary goal of treatment is to improve a patient's quality of life by addressing the specific symptoms and underlying cause where possible.